As the novel coronavirus (COVID-19) continues to spread across the world, our analysts are constantly tracking the impact of this rapidly evolving situation on the markets and the consumer purchase behaviours. Thus, our latest estimates and analysis about the current market trends and forecast will exhaustively reflect the effects of this emerging pandemic.

Global Liquid Biopsy Market: By Application: Therapy Selection for Metastatic Breast Cancer, Therapy Selection for Other Metastatic Cancer, Others; By Sample Type; By Biomarker; By Technology; Regional Analysis; Historical Market and Forecast (2016-2026); Market Dynamics; Competitive Landscape; Industry Events and Developments

Global Liquid Biopsy Market Outlook

The global liquid biopsy market stood at a value of around USD 1,250 million in 2020. The market is further expected to grow at a CAGR of 22% in the forecast period of 2021-2026 to attain a value of USD 4,122 million by 2026.

 

Circulating Tumour DNA Segment to Aid the Overall Growth of the Global Liquid Biopsy Industry

Based on the biomarker, the circulating tumour DNA segment is estimated to hold a considerable share in the global liquid biopsy industry during the forecast period. This growth can be attributed to the rapid technological advancements, such as the application of next-generation sequencing technologies in the liquid biopsy process for the circulating tumour DNA biomarker analysis.

 

Global Liquid Biopsy Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Furthermore, in terms of application, the therapy selection for the metastatic breast cancer segment is expected to observe a significant increase due to the promising results yielded in the variety of studies analysing the scope of liquid biopsies. Liquid biopsy contributed especially in the process of treatment response monitoring and disease progression estimation for breast cancers.

 

The Asia Pacific Region to Account for a Significant Share in the Global Liquid Biopsy Industry

The Asia Pacific region is predicted to possess a significant share of the global liquid biopsy industry. This surge can be attributed to the rising incidences of cancer in the region. According to Global Cancer Statistics 2020 issued by GLOBOCAN, the Asia Pacific region accounted for 58.3% of the overall cancer death worldwide. In addition, governments are increasingly investing in the development of the healthcare infrastructure and the advancement of liquid biopsy profiling methodologies, which is expected to further contribute to the market growth in the region.

 

Liquid Biopsy: Industry Definition and Segmentation

Liquid biopsy is a non-invasive method, as opposed to surgical biopsy, in tumour molecular profiling, where a doctor need not obtain the tumour tissue directly. Instead, physicians can analyse the biomarkers, that is, circulating tumour cells and circulating cell-free tumour DNA present in the blood drawn from a person's arm or a urine sample to detect and characterise tumours. This method is useful in the early detection of cancer and helps monitor the tumour growth and assess the clinical approach to be taken in terms of treatment.

By application, the market is distributed into:

  • Therapy Selection for Metastatic Breast Cancer 
  • Therapy Selection for Other Metastatic Cancer
  • Molecular Health Monitoring

On the basis of sample type, the industry can be categorised into:

  • Blood Sample Based 
  • Urine Sample Based
  • Others

Based on biomarker, the market can be segmented into:

  • Circulating Tumour Cells
  • Circulating Tumour DNA
  • Exosomes

On the basis of technology, the industry can be bifurcated into:

  • Multi-Gene-Parallel Analysis Using NGS
  • Single Gene Analysis Using PCR Microarrays

The regional markets for the product include North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

 

Escalating Cases of Cancer Worldwide to Catalyse the Market Growth of the Global Liquid Biopsy Industry

Liquid biopsy is an emerging tumour analysing method that is steadily gaining precedence in the market. This is mainly due to the rampant spread of cancer worldwide. According to the WHO statistics, cancer is a leading cause of death, with more than 10 million deaths recorded in 2020. Furthermore, out of all the cancer variations, breast cancer is the most prevalent in the world. In this regard, the WHO defines the early detection of cancer and appropriate treatment as a strategic method in reducing the number of cancer fatalities, as in the early stages, many cancer variations can be cured. As a result, governments and many international agencies are introducing initiatives to implement and develop liquid biopsy methodologies. For example, the bloodPAC project, a US-based Blood Profiling Atlas in Cancer Consortium, published validation protocols for liquid biopsy, reviewed by the FDA, to develop and define industry standards for liquid biopsy. These factors are expected to aid the market growth in the forecast period.

 

Key Industry Players in the Global Liquid Biopsy Market

The report gives a detailed analysis of the following key players in the global liquid biopsy market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:

  • Biocept, Inc.
  • F. Qiagen N.V.
  • Bio-Rad Laboratories, Inc.
  • NeoGenomics Laboratories, Inc.
  • Guardant Health, Inc. 
  • Others

The comprehensive EMR report provides an in-depth assessment of the industry based on the Porter's five forces model and SWOT analysis.

 

REPORT FEATURES DETAILS
Base Year 2020
Historical Period 2016-2020
Forecast Period 2021-2026
Scope of the Report Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Application, Sample Type, Biomarker, Technology, Region
Breakup by Application Therapy Selection for Metastatic Breast Cancer, Therapy Selection for Other Metastatic Cancer, Molecular Health Monitoring
Breakup by Sample Type Blood Sample Based, Urine Sample Based, Others
Breakup by Biomarker Circulating Tumor Cells, Circulating Tumor DNA, Exosomes
Breakup by Technology Multi-Gene-Parallel Analysis Using NGS, Single Gene Analysis Using PCR Microarrays
Breakup by Region North America, Europe, Asia Pacific, Latin America, Middle East and Africa
Market Dynamics SWOT, Porter's Five Forces, EMR’s Key Indicators for Price and Demand
Competitive Landscape Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications
Companies Covered Biocept, Inc., F. Qiagen N.V., Bio-Rad Laboratories, Inc., NeoGenomics Laboratories, Inc., Guardant Health, Inc., Others
Report Price and Purchase Option Explore our purchase options that are best suited to your resources and industry needs.
Delivery Format Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.

 

*We at Expert Market Research always thrive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.

1    Preface
2    Report Coverage – Key Segmentation and Scope
3    Report Description

    3.1    Market Definition and Outlook
    3.2    Properties and Applications
    3.3    Market Analysis
    3.4    Key Players
4    Key Assumptions
5    Executive Summary

    5.1    Overview
    5.2    Key Drivers
    5.3    Key Developments
    5.4    Competitive Structure
    5.5    Key Industrial Trends
6    Snapshot
    6.1    Global
    6.2    Regional
7    Industry Opportunities and Challenges
8    Global Liquid Biopsy Market Analysis

    8.1    Key Industry Highlights
    8.2    Global Liquid Biopsy Market Historical Market (2016-2020) 
    8.3    Global Liquid Biopsy Market Forecast (2021-2026)
    8.4    Global Liquid Biopsy Market by Application
        8.4.1    Therapy Selection for Metastatic Breast Cancer
            8.4.1.1    Market Share
            8.4.1.2    Historical Trend (2016-2020)
            8.4.1.3    Forecast Trend (2021-2026)
        8.4.2    Therapy Selection for Other Metastatic Cancer
            8.4.2.1    Market Share
            8.4.2.2    Historical Trend (2016-2020)
            8.4.2.3    Forecast Trend (2021-2026)
        8.4.3    Molecular Health Monitoring
            8.4.3.1    Market Share
            8.4.3.2    Historical Trend (2016-2020)
            8.4.3.3    Forecast Trend (2021-2026)
    8.5    Global Liquid Biopsy Market by Sample Type
        8.5.1    Blood Sample Based
            8.5.1.1    Market Share
            8.5.1.2    Historical Trend (2016-2020)
            8.5.1.3    Forecast Trend (2021-2026)
        8.5.2    Urine Sample Based
            8.5.2.1    Market Share
            8.5.2.2    Historical Trend (2016-2020)
            8.5.2.3    Forecast Trend (2021-2026)
        8.5.3    Others
    8.6    Global Liquid Biopsy Market by Biomarker
        8.6.1    Circulating Tumor Cells
            8.6.1.1    Market Share
            8.6.1.2    Historical Trend (2016-2020)
            8.6.1.3    Forecast Trend (2021-2026)
        8.6.2    Circulating Tumor DNA
            8.6.2.1    Market Share
            8.6.2.2    Historical Trend (2016-2020)
            8.6.2.3    Forecast Trend (2021-2026)
        8.6.3    Exosomes
            8.6.3.1    Market Share
            8.6.3.2    Historical Trend (2016-2020)
            8.6.3.3    Forecast Trend (2021-2026)
    8.7    Global Liquid Biopsy Market by Technology
        8.7.1    Multi-Gene-Parallel Analysis Using NGS
            8.7.1.1    Market Share
            8.7.1.2    Historical Trend (2016-2020)
            8.7.1.3    Forecast Trend (2021-2026)
        8.7.2    Single Gene Analysis Using PCR Microarrays
            8.7.2.1    Market Share
            8.7.2.2    Historical Trend (2016-2020)
            8.7.2.3    Forecast Trend (2021-2026)
    8.8    Global Liquid Biopsy Market by Region
        8.8.1    Market Share
            8.8.1.1    North America
            8.8.1.2    Europe
            8.8.1.3    Asia Pacific
            8.8.1.4    Latin America
            8.8.1.5    Middle East and Africa
9    Regional Analysis
    9.1    North America
        9.1.1    Historical Trend (2016-2020)
        9.1.2    Forecast Trend (2021-2026)
        9.1.3    Breakup by Country
            9.1.3.1    United States of America 
            9.1.3.2    Canada
    9.2    Europe
        9.2.1    Historical Trend (2016-2020)
        9.2.2    Forecast Trend (2021-2026)
        9.2.3    Breakup by Country 
            9.2.3.1    United Kingdom
            9.2.3.2    Germany
            9.2.3.3    France
            9.2.3.4    Italy
            9.2.3.5    Others
    9.3    Asia Pacific
        9.3.1    Historical Trend (2016-2020)
        9.3.2    Forecast Trend (2021-2026)
            9.3.2.1    Breakup by Country
            9.3.2.2    China
            9.3.2.3    Japan
            9.3.2.4    India
            9.3.2.5    ASEAN
            9.3.2.6    Australia
            9.3.2.7    Others
    9.4    Latin America
        9.4.1    Historical Trend (2016-2020)
        9.4.2    Forecast Trend (2021-2026)
        9.4.3    Breakup by Country
            9.4.3.1    Brazil
            9.4.3.2    Argentina
            9.4.3.3    Mexico
            9.4.3.4    Others
    9.5    Middle East and Africa
        9.5.1    Historical Trend (2016-2020)
        9.5.2    Forecast Trend (2021-2026)
        9.5.3    Breakup by Country
            9.5.3.1    Saudi Arabia
            9.5.3.2    United Arab Emirates
            9.5.3.3    Nigeria
            9.5.3.4    South Africa
            9.5.3.5    Others
10    Market Dynamics
    10.1    SWOT Analysis
        10.1.1    Strengths
        10.1.2    Weaknesses
        10.1.3    Opportunities
        10.1.4    Threats
    10.2    Porter’s Five Forces Analysis
        10.2.1    Supplier’s Power
        10.2.2    Buyer’s Power
        10.2.3    Threat of New Entrants
        10.2.4    Degree of Rivalry
        10.2.5    Threat of Substitutes
    10.3    EMR’s Key Indicators for Demand
    10.4    EMR’s Key Indicators for Price
11    Value Chain Analysis
12    Competitive Landscape

    12.1    Market Structure
    12.2    Company Profiles
        12.2.1    Biocept, Inc.
            12.2.1.1    Company Overview
            12.2.1.2    Product Portfolio
            12.2.1.3    Demographic Reach and Achievements
            12.2.1.4    Certifications
        12.2.2    F. Qiagen N.V.
            12.2.2.1    Company Overview
            12.2.2.2    Product Portfolio
            12.2.2.3    Demographic Reach and Achievements
            12.2.2.4    Certifications
        12.2.3    Bio-Rad Laboratories, Inc.
            12.2.3.1    Company Overview
            12.2.3.2    Product Portfolio
            12.2.3.3    Demographic Reach and Achievements
            12.2.3.4    Certifications
        12.2.4    NeoGenomics Laboratories, Inc.
            12.2.4.1    Company Overview
            12.2.4.2    Product Portfolio
            12.2.4.3    Demographic Reach and Achievements
            12.2.4.4    Certifications
        12.2.5    Guardant Health, Inc.
            12.2.5.1    Company Overview
            12.2.5.2    Product Portfolio
            12.2.5.3    Demographic Reach and Achievements
            12.2.5.4    Certifications
        12.2.6    Others
13    Industry Events and Developments

 

List of Figures and Tables

1.    Global Liquid Biopsy Market: Key Industry Highlights, 2016 and 2026
2.    Global Liquid Biopsy Historical Market: Breakup by Application (USD Million), 2016-2020
3.    Global Liquid Biopsy Market Forecast: Breakup by Application (USD Million), 2021-2026
4.    Global Liquid Biopsy Historical Market: Breakup by Sample Type (USD Million), 2016-2020
5.    Global Liquid Biopsy Market Forecast: Breakup by Sample Type (USD Million), 2021-2026
6.    Global Liquid Biopsy Historical Market: Breakup by Biomarker (USD Million), 2016-2020
7.    Global Liquid Biopsy Market Forecast: Breakup by Biomarker (USD Million), 2021-2026
8.    Global Liquid Biopsy Historical Market: Breakup by Technology (USD Million), 2016-2020
9.    Global Liquid Biopsy Market Forecast: Breakup by Technology (USD Million), 2021-2026
10.    Global Liquid Biopsy Historical Market: Breakup by Region (USD Million), 2016-2020
11.    Global Liquid Biopsy Market Forecast: Breakup by Region (USD Million), 2021-2026
12.    North America Global Liquid Biopsy Historical Market: Breakup by Country (USD Million), 2016-2020
13.    North America Global Liquid Biopsy Market Forecast: Breakup by Country (USD Million), 2021-2026
14.    Europe Global Liquid Biopsy Historical Market: Breakup by Country (USD Million), 2016-2020
15.    Europe Global Liquid Biopsy Market Forecast: Breakup by Country (USD Million), 2021-2026
16.    Asia Pacific Global Liquid Biopsy Historical Market: Breakup by Country (USD Million), 2016-2020
17.    Asia Pacific Global Liquid Biopsy Market Forecast: Breakup by Country (USD Million), 2021-2026
18.    Latin America Global Liquid Biopsy Historical Market: Breakup by Country (USD Million), 2016-2020
19.    Latin America Global Liquid Biopsy Market Forecast: Breakup by Country (USD Million), 2021-2026
20.    Middle East and Africa Global Liquid Biopsy Historical Market: Breakup by Country (USD Million), 2016-2020
21.    Middle East and Africa Global Liquid Biopsy Market Forecast: Breakup by Country (USD Million), 2021-2026
22.    Global Liquid Biopsy Market Structure

Purchase Full Report

Mini Report

$1499
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$2699
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

$3699
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$4699
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

RIGHT PEOPLE

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

RIGHT METHODOLOGY

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

RIGHT PRICE

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

RIGHT SUPPORT

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

Similar Reports





NEWSLETTER